Lonza Raises 2016 Outlook as Profit Jumps on Savings, Demand
Lonza Group AG raised its guidance for 2016 after demand for the Swiss company’s drug ingredient manufacturing services grew and savings bolstered margins in the first half.
Lonza Group AG raised its guidance for 2016 after demand for the Swiss company’s drug ingredient manufacturing services grew and savings bolstered margins in the first half.